Table 3. Costs of drug treatments in the sequencing model for the United Kingdom.
| Dose | Days each unit prescribed | Costs per cycle | |
|---|---|---|---|
| Fulvestrant | 250 mg every 4 weeks | 28 | £348.27 |
| NSAI (anastrazole)a | 1 mg daily | 28 | £68.56 |
| Exemestane | 25 mg daily | 28 | £82.88 |
| Docetaxel | 100 mg/1.73 m2 | 21 | £1,254.00 |
| Capecitabine | Dose 1250 mg/m2 twice daily for 14 days, then 7 days interval | 21 | £296.24 |
a
The cost is similar to letrozole and is assumed that clinical behaviour is most likely to be independent of non-steroidal AI used.
Source: British National Formulary, 2006 (British National Formulary, 2006).